[Chemotherapy with concomitant IFN treatment in three HBV carriers (mutant strain) with malignant lymphoma].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Chemotherapy with concomitant IFN treatment in three HBV carriers (mutant strain) with malignant lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Aug 1995

Niitsu N, Nakayama M, Umeda M

Abstract excerpt

Intensive multidrug chemotherapy with concomitant IFN was performed in three hepatitis B virus (HBV) carriers with malignant lymphomas. All of the patients were HBsAg+, HBsAb-, HBcAb+, HBeAg- and HBeAb+ (mutant strain+). HBV-DNA polymerase (DNA-P) was normal at the beginning of chemotherapy, and...

Topics

Aged
Antineoplastic Combined Chemotherapy Protocols
Antiviral Agents
Bleomycin
Carrier State
Cyclophosphamide
Doxorubicin
Hepatitis B
Hepatitis B virus
Humans
Interferon-alpha
Lymphoma, Non-Hodgkin
Male
Middle Aged
Mutation
Vincristine

Source

Open in PubMed

Identifiers

PMID: 7563613

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7563613-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics